Investment Guide 2026

How to Invest in Neimeth International Pharmaceuticals Plc (NEIMETH.NG) in Nigeria.

Direct institutional-grade access to Neimeth International Pharmaceuticals Plc on the Nigerian Exchange Group with unified USD settlement.

NEIMETH.NG
Live Registry Node
NGN2.10
0.00% (1D)
Delayed Data (15m)

Market Cap: ₦8.42B

Institutional Profile

Neimeth International Pharmaceuticals Plc is a leading Nigerian pharmaceutical manufacturer specializing in the production of generic and branded pharmaceutical products, including anti-infectives, family health products, and nutritional supplements. Formerly the Nigerian subsidiary of Pfizer, it serves both local and regional West African markets.

Industry Sector

Healthcare

Why Investors Consider NEIMETH.NG

  • Market leadership in a critical economic sector.
  • Consistent dividend payout history.
  • Strategic exposure to regional growth fundamentals.

How to Invest via mystocks.africa

Follow this 2026 roadmap to initialize your position on the Nigerian Exchange Group.

01

Create a free account on mystocks.africa

02

Complete KYC verification using your BVN and a valid ID

03

Fund your mystocks.africa wallet via bank transfer

04

Search for Neimeth International Pharmaceuticals Plc in the NGX market section

05

Place your buy order and confirm the transaction

06

Monitor your holdings in your mystocks.africa portfolio

Own the Future.

Join the largest retail bridge to the African capital markets. Open your free account and execute your first trade in minutes.

Market Knowledge